Avid Bioservices Inc (NASDAQ: CDMO) Emerges As Guiding Light For Investors

Avid Bioservices Inc (NASDAQ:CDMO) currently has a daily average trading volume of 1.50M but it saw 8275282 shares traded in last market. With a market cap of 762.99M USD, the company’s current market price of $11.93 came falling about -2.21 while comparing to the previous closing price of $12.20. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.48 and as low as $4.07. In the recent trading on the day, stock has struck highest price mark of $11.6901 while lowest mark touched by it was $12.24.

Taking a look at 20-day trading activity of Avid Bioservices Inc (CDMO) gives us an average price of $10.84, while its current price level is -4.41% below from 52-week high level whereas it is 193.08% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $10.78 while that of 200 days or SMA-200 reads an average of $8.80. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.42% during that period while stretching the period over a month that increases to 3.33%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 66.12 which implies that the stock is in neutral territory.

KeyBanc Capital Markets upgraded its recommendation for the stock as a “Overweight” from “Sector Weight” on March 14, 2023 while assigning a price target of $20.

Over the week, CDMO’s stock price is moving -2.53% down while it is 16.96% when we observe its performance for the past one month. Year-to-date it is 83.54% up and over the past year, the stock is showing an upside performance of 118.10%.

Currently, Avid Bioservices Inc’s total number of outstanding shares is 63.57M. Company’s return on investment (ROI) stands at -54.77% and return on equity (ROE) at -115.84%. Stock’s beta reads 1.44. Stock has a price to book (P/B) ratio of 12.98 while price to sale or P/S ratio amounts to 5.36. Its return on asset (ROA) is -37.08% on average.